Canada markets closed

MaaT Pharma SA (4RD.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
6.54+0.18 (+2.83%)
At close: 03:29PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,228
2,228
1,430
972
0
-
Cost of Revenue
573
573
339
166
0
-
Gross Profit
1,655
1,655
1,091
806
0
-
Operating Expenses
Research Development
21,006
21,006
14,476
9,252
6,099
-
Selling General and Administrative
3,001
3,001
1,963
1,372
658
-
Total Operating Expenses
21,599
21,599
14,647
9,698
5,221
-
Operating Income or Loss
-19,944
-19,944
-13,556
-8,892
-5,221
-
Interest Expense
402
402
185
121
45
-
Income Before Tax
-19,717
-19,717
-13,713
-9,019
-5,301
-
Income Tax Expense
-
-
0
0
0
0
Income from Continuing Operations
-19,717
-19,717
-13,713
-9,019
-5,301
-
Net Income
-19,717
-19,717
-13,713
-9,019
-5,301
-
Net Income available to common shareholders
-19,717
-19,717
-13,713
-9,019
-5,301
-
Basic EPS
-1.40
-1.70
-1.40
-3.70
-5.10
-
Diluted EPS
-1.40
-1.70
-1.40
-3.70
-5.10
-
Basic Average Shares
10,513
11,365
9,892
2,427
1,032
-
Diluted Average Shares
10,513
11,365
9,892
2,427
1,032
-